Chris M. Smith has been a Senior Advisor to EQT since March 2018.
Chris retired as CEO and President of Cochlear, an ASX listed company, in January 2018 after 14 years with the company. Prior to Cochlear, Chris was with Warburg Pincus as a CEO in Residence, and prior to that he was Global Group President for Gyrus Plc, a FTSE listed company, and CEO of Gyrus Medical. Chris began his career at Abbott and spent more than 30 years working in the healthcare sector with a primary focus on the MedTech industry.
Chris graduated from Texas A&M University with a Bachelor of Science.